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Pesticides are a diverse group of chemical
compounds and consist of insecticides, fungi-
cides, herbicides, and rodenticides. Pesticides
have contributed to dramatic increases world-
wide in crop yields and have helped to limit the
spread of disease. But pesticides also have
harmful effects and can injure human health as
well as the environment. The range of these
adverse health effects includes acute and persis-
tent injury to the nervous system, lung damage,
injury to the reproductive organs, dysfunction
of the immune and endocrine system, birth
defects, and cancer (Landrigan et al. 1999).
Since passage of the Food Quality
Protection Act (FQPA) in 1996 [U.S.
Environmental Protection Agency (EPA)
2003b], chemical manufacturers have, with
increasing frequency, assessed the toxicity
of pesticides by testing them in human vol-
unteers [Environmental Working Group
(EWG) 1999]. The apparent purpose of these
tests is to establish safe or threshold limits
for human exposure, termed “no observable
effect levels” (NOELs).
The acceptance by the U.S. EPA of human
test results in standard setting raises ethical
and policy concerns (Robertson and Gorovitz
2000; Steinberg 2000). These issues include the
absence of mandatory ethical guidelines for
research conducted by pesticide manufacturers
and submitted to the U.S. EPA, the absence of
procedures for minimizing harm to study par-
ticipants and for subjecting them to no unrea-
sonable risk, and the use of approaches for
obtaining informed consent by subjects
participating in these studies that may be less
stringent than those speciﬁed by the Common
Rule (Ofﬁce of Science and Technology Policy
1991). Others have argued in favor of the value
of testing pesticides in humans on the grounds
that data obtained in humans are the best pre-
dictor of human toxicity (McConnell 2001).
To consider these issues, the Center for
Children’s Health and the Environment of
the Mount Sinai School of Medicine convened
an expert workshop titled “Pesticide Testing
in Humans: Ethics and Public Policy” on
27 February 2002. All workshop participants
had nationally recognized expertise in the
areas of ethics, children’s health, federal pol-
icy, and toxicology. Participants were selected
based on established national reputations and
extensive publication records. Efforts were
made to select a broad sample of participants
that included representatives of academia,
industry, and nonprofit advocacy organiza-
tions, representing various points of view.
Areas of agreement were recorded during the
1-day workshop. Further debate around some
contentious issues continued during a 6-month
period after the workshop, and finally this
process resulted in a series of recommendations.
In this report, we review the history of pesticide
testing in humans and summarize the ethical
and policy recommendations developed and
supported by the participants.
Background
The history of federal regulation of pesticides
over the past ﬁve decades reﬂects an increasing
awareness of the adverse effects of pesticides
on human health. It embodies the realization
that pesticides can have harmful effects at lev-
els previously thought to be safe, especially in
vulnerable populations such as infants and
children. Recognition of the inherent dangers
of pesticides has led to the development of
regulations intended to protect human health
from pesticide exposure.
The U.S. Insecticides, Fungicides, and
Rodenticides Act (FIFRA) of 1947 (U.S. EPA
2003a) is the primary federal statute govern-
ing the registration and use of pesticides in
the United States. FIFRA requires the U.S.
government to register all pesticides before
their introduction in interstate commerce.
Under FIFRA, no person may sell, distribute,
or use a pesticide unless it is registered by
the U.S. EPA. In 1964, Congress passed an
amendment to FIFRA that authorized the
Secretary of Agriculture to refuse registration
to pesticides that were unsafe or ineffective
and to remove them from the market (U.S.
EPA 2003a).
In 1970, Congress transferred the adminis-
tration of FIFRA to the newly created U.S.
EPA. This initiated a shift in federal policy
toward greater emphasis on minimizing risks
of pesticides to human health and the environ-
ment, and away from an older, economically
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Pesticide manufacturers have tested pesticides increasingly in human volunteers over the past decade.
The apparent goal of these human studies is to establish threshold levels for symptoms, termed “no
observed effect levels.” Data from these studies have been submitted to the U.S. Environmental
Protection Agency (EPA) for consideration in standard setting. There are no required ethical guide-
lines for studies of pesticides toxicity conducted in humans, no governmental oversight is exercised,
and no procedures have been put in place for the protection of human subjects. To examine ethical
and policy issues involved in the testing of pesticides in humans and the use of human data in stan-
dard setting, in February 2002 the Center for Children’s Health and the Environment of the Mount
Sinai School of Medicine convened an expert workshop for ethicists, physicians, toxicologists, and
policy analysts. After a peer consensus process, participants developed a number of ethical and public
policy recommendations regarding the testing of pesticides in humans. Participants also strongly
encouraged active biomonitoring of every pesticide currently in use to track human exposure, partic-
ularly in vulnerable populations, and to assess adverse effects on health. Key words: biomonitoring,
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Environmental Medicine Workgroup Reportbased paradigm that focused principally on
issues of pesticide efﬁcacy in agricultural pro-
duction (U.S. EPA 2003a). This new policy
focus was expanded by passage of the U.S.
Environmental Pesticide Control Act of 1972,
which amended FIFRA by specifying methods
and standards of control in greater detail (U.S.
EPA 2003a).
In 1996, the FQPA was unanimously
passed by the U.S. Congress and signed into
law. FQPA amended FIFRA yet again, funda-
mentally changing the way in which the U.S.
EPA regulates pesticides (U.S. EPA 2003b).
The law requires the U.S. EPA to reassess
> 9,000 current pesticide residue tolerances
by 2006. The FQPA explicitly requires the
U.S. EPA to make the protection of human
health the primary goal of pesticide regula-
tion; it also requires the U.S. EPA to address
risks to infants and children and to publish a
specific safety finding before a tolerance can
be established. Further, it provides for an
additional safety factor (10-fold, unless reli-
able data show that a different factor will be
safe) to ensure that tolerances are safe for
infants and children, and it requires collection
of better data on food consumption patterns,
pesticide residue levels, and pesticide use
(U.S. EPA 2003b).
U.S. EPA standard-setting procedures.
For many years the U.S. EPA has relied on
studies conducted by private industry in for-
mulating exposure standards for pesticides.
Traditionally, pesticide standards have been
based on toxicity assessments in rodent
species. The goal of such testing is to define
the toxicology proﬁle of the pesticide and to
establish symptom thresholds or NOELs, also
known as NOAELs (no observed adverse
effect levels) or LOAELs (lowest observed
adverse effect levels). A NOEL is defined as
an exposure level at which there is no statisti-
cally or biologically signiﬁcant increase in the
frequency or severity of any effect between
the exposed population and its appropriate
control (U.S. EPA 1999a). Two 10-fold
safety factors are then applied. First, the
NOEL observed in rodents is divided by a
factor of 10 to account for the extrapolation
from rodent to human. Then that number is
divided by a second factor of 10 to account
for variation among humans. Thus, the tradi-
tional practice had been to determine the
NOEL in animals, divide that number by
100, and on that basis calculate the pesticide
standard, termed a “reference dose” or “toler-
ance” (EWG 1999).
After the passage into law of FQPA, the
U.S. EPA has been required, in certain
instances—especially where developmental
toxicity is suspected or where data on develop-
mental toxicity are lacking—to apply a third
child-protective safety factor of up to 10-fold
and thus to divide the NOEL obtained in
animals by a factor of as much as 1,000 (103)
in setting human standards (U.S. EPA
2003b). Some pesticide manufacturers have
increasingly undertaken testing in humans,
thus bypassing the need for the first 10-fold
safety factor. Testing in humans may render
unnecessary the safety factor that accounts for
the extrapolation from animals to humans.
The net effect is that the NOELs determined
in humans must be divided by a factor of only
up to 100 to comply with the FQPA (U.S.
EPA 2003b).
FQPA also requires the U.S. EPA to con-
sider the cumulative effects on human health
that may result from multiple exposures to
many pesticides (U.S. EPA 2003b). For exam-
ple, both organophosphate and carbamate pes-
ticides exert their toxic effects through the
inhibition of cholinesterase. Therefore, risk
assessment involving organophosphate pesti-
cides must now involve consideration of the
potential cumulative health effects of the addi-
tional exposure to carbamate pesticides. This
requirement has created an additional incen-
tive for pesticide manufacturers to perform
human testing to relax the U.S. EPA pesticide
tolerance thresholds.
Human testing of pesticides. Since the
1960s, chemical companies have submitted
studies to the U.S. EPA in which human
research subjects were exposed to pesticides. In
1973 New York State prisoners were fed small
amounts of the organophosphate pesticide
chlorpyrifos and monitored for weeks to deter-
mine adverse effects at various exposure levels
(Warrick 2000). A 1992 study, conducted on
38 men and 9 women by Inveresk Research in
Edinburgh, Scotland, for the French chemical
company Rhone-Poulenc Agro of Lyon,
France, had participants drink orange juice
that contained either a placebo or various
doses of the carbamate insecticide aldicarb.
Some participants experienced side effects that
included sweating, light-headedness, and
headaches (EWG 1999). A 1994 study at the
University of California at Davis, funded by
the Amvac Chemical Corporation (Newport
Beach, CA), involved 70 paid human volun-
teers. Participants were exposed to methyl
isothiocyanate, the active ingredient in the soil
fumigant metam sodium (Wadman 1998).
The pace of pesticide testing in humans
appears to have accelerated in recent years. In
the decade before the passage of FQPA in
1996, only a handful of human tests were
submitted to the U.S. EPA. In the subsequent
3 years, the U.S. EPA received 14 new unso-
licited human subject studies on 10 different
pesticides (Shogren 2001). Two examples
involve the organophosphate insecticides
dichlorvos and chlorpyrifos.
Dichlorvos is classiﬁed by the U.S. EPA as
a “suggestive carcinogen” and “is a direct acting
mutagen in in vitro mammalian test systems”
(U.S. EPA 2000b). Additionally, “following a
single oral dose to rats, dichlorvos was associ-
ated with a variety of neurological and phys-
iological changes” (U.S. EPA 2000b). The
U.S. EPA reports that “there is a concern that
dichlorvos may affect brain development, and
that it may do so in ways not measured in stan-
dard developmental toxicity tests” (U.S. EPA
2000b). In 1997, Medeval Ltd. in Manchester,
England, conducted three studies funded by
Amvac, in which a small number of adult
men in Britain were paid to ingest dichlorvos
dissolved in corn oil (EWG 1999).
In 1998, after signing a seven-page con-
sent form, dozens of college-age Nebraskans
were paid $450 to swallow a pill containing
chlorpyrifos. Chlorpyrifos is the active ingre-
dient in Raid roach spray, manufactured by
the Dow Chemical Company (Midland, MI).
The students learned about this study after
reading school newspaper ads urging students
to call (402) 474-PAYS to “earn extra money”
(Lemonic and Goldstein 2002).
The English Patients. Publication of The
English Patients: Human Experiments and
Public Policy by the EWG in 1999 was a land-
mark event in raising concern about the
ethical and policy issues surrounding human
testing of pesticides. This report noted that
federal health agencies such as the National
Institutes of Health and the U.S. Food and
Drug Administration (FDA) have rules gov-
erning the ethics and scientiﬁc quality of stud-
ies submitted for research purposes—the
so-called Common Rule (Office of Science
and Technology Policy 1991)—but that the
U.S. EPA has no such guidelines. The report
focused public attention on small-scale indus-
try studies in human adults that were being
used by the U.S. EPA to set pesticide safety
levels for the entire population of the United
States, children included (EWG 1999).
The English Patients noted that a number of
the human studies it examined had failed to
meet the scientiﬁc standards of contemporary
research. Some of the studies were based on
< 15 participants, all of them adults. Thus, they
contained too few subjects to permit statistically
valid answers to the questions under investiga-
tion, and they provided no information on
developmental or pediatric toxicity. The report
also noted that the U.S. EPA does not require
companies that conduct human experiments to
follow any human subjects protection protocol
(EWG 1999). The English Patients concluded
with three recommendations (EWG 1999):
1. The EPA should conduct a review of past and
current human experimentation in the context of
environmental policy making.
2. EPA should impose an immediate moratorium
on human experimentation, of the type conducted
for dichlorvos, aldicarb, and other pesticides for
purposes of pesticide registration until an ethical
review has been completed.
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and prior to any relaxation of the moratorium on
the use of human experiments for pesticide regis-
tration, EPA should promulgate and adopt policy
guidelines and procedures for pesticide testing.
Last, the EWG argued that the use of
human test results derived solely in adults
provides no data on developmental toxicity
and thus fails to fulﬁll the intent of the extra
10-fold child-protective safety factor required
by FQPA (EWG 1999).
U.S. EPA Scientiﬁc Advisory
Board and Scientiﬁc Advisory
Panel
Responding to public and professional concern
about the testing of pesticides in humans,
in December 1998 the U.S. EPA convened
a joint meeting of the agency’s Scientific
Advisory Board (SAB) and Scientiﬁc Advisory
Panel (SAP). To formulate ethical guidelines
for pesticide testing in humans, the group con-
vened a public meeting on 10–11 December
1998 and issued a draft report. Because aspects
of that report diverged from the tenor of the
meeting, certain members of the committee
refused to sign the report. After a yearlong
stalemate, a second meeting was convened on
30 November 1999. The group issued its ﬁnal
report on 11 September 2000. This report
included a minority statement dissenting from
several key ﬁndings of the main report (U.S.
EPA 1999b, 2000a).
A unanimous finding of the committee
was that bad science is inherently unethical.
The report stated that “Bad science is always
unethical; research protocols that are funda-
mentally ﬂawed such as those with sample sizes
inadequate to support reasonable inferences
about the matter in question are unjustiﬁable.”
The committee found that the cases of pesti-
cide testing on human subjects that it was able
to examine all relied on sample sizes far too
small to yield statistically meaningful results.
For these reasons, members of the committee
raised no objections at the meeting to a pro-
posal to disallow human testing as a means of
establishing NOELs for pesticides. However,
the final majority report diverged from the
tenor of the meeting, stating instead that “If it
can be justiﬁed at all to expose human subjects
intentionally to toxic substances, the threshold
of justification for such an action should be
very high” (U.S. EPA 1999b, 2000a).
Addressing the risk of harm to research sub-
jects, the report stated that “it is not enough to
determine a risk/beneﬁt ratio; it is important to
consider the distribution of risks and beneﬁts,
and to insure that risks are not imposed on
one population for the sake of beneﬁts to be
enjoyed by another.” Additionally, the report
stated, “Any policy adopted by the agency
should reﬂect the highest standards of respect
for human subjects and should prohibit
research protocols that override the interests
of subjects in order to obtain useful data” (U.S.
EPA 1999b, 2000a).
Ultimately, the committee could not
agree unanimously whether there are circum-
stances under which pesticide testing on
human subjects can be justified. The final
report states, “it agreed that, generally, human
dosing experiments are not appropriate if the
primary intent of the study is to determine or
revise a NOEL or NOAEL so as to eliminate
the interspecies uncertainty factor” (U.S. EPA
1999b). However, this statement was not
included in the executive summary or major
recommendations (U.S. EPA 1999b, 2000a).
The committee concluded that “if the use
of human subjects in pesticide testing can be
justiﬁed, that justiﬁcation cannot be to facili-
tate the interests of industry or agriculture, but
only to better safeguard the public health”
(U.S. EPA 1999b). Various committee mem-
bers expressed doubt about the U.S. EPA’s
ability to translate this concern into enforce-
able regulations, but all members agreed with
the basic principle. Although noting the lack
of consensus, the final majority report sug-
gested that pesticide testing on human sub-
jects would be permissible if all such research
were reviewed in advance by an institutional
review board in accordance with the protec-
tions of the Common Rule (Ofﬁce of Science
and Technology Policy 1991) and subject to
scrutiny by the U.S. EPA. Furthermore, the
majority report recommended that such stud-
ies be well designed, refrain from exposing
developing humans to neurotoxic chemicals,
and provide information not available via ani-
mal studies, study of incidental exposures, or
other sources (U.S. EPA 1999b, 2000a).
Two committee members issued a minor-
ity report that dissented from the majority
report in several areas. It expressed concern
that the ﬁnal report did not accurately reﬂect
the earlier consensus of the panel members.
The dissenters, both of them pediatricians,
argued that the ﬁnal draft of the report was a
“distorted and diluted version of the public
proceedings of the subcommittee” and “if
accepted, it will serve to increase the health
risks of children from pesticide exposure” (U.S.
EPA 1999b). The minority report explained
that during the December 1998 meeting most
of the members had expressed strong doubts
about both the ethics and scientiﬁc validity of
exposing humans to organophosphate pesti-
cides, but that the ﬁrst drafts of the proceed-
ings did not reflect this consensus. The
minority report went on to state that the subse-
quent draft reports contain many misrepresen-
tations of statements made by committee
members, as recorded in the transcript of the
proceedings (U.S. EPA 1999b, 2000a).
The minority report stated that the final
report minimizes the risks to humans from
intentional experimental dosing and deempha-
sizes the issue that “no limited human study
will provide information about safe levels of
intake of pesticides by humans, especially chil-
dren” (U.S. EPA 1999b). The minority report
also argued that the ﬁnal report did not ade-
quately address the need for large numbers of
subjects to achieve sufﬁcient statistical power
to find a small effect, and that the overly
small human studies done by pesticide manu-
facturers were scientifically invalid for this
reason alone. It stated that to find a small
effect, at least 2,500 subjects in each group
were necessary and that, with the sample sizes
of 7–50 subjects used in industry studies,
there was a 3–4% chance of ﬁnding an effect.
The minority report concluded that the
“there is strong documentation that the
human studies done by the pesticide manu-
facturers were scientifically invalid” (U.S.
EPA 1999b, 2000b).
Recent Developments
During 1999, in response to mounting criti-
cism from environmentalists and physicians,
the Clinton administration directed the U.S.
EPA to stop accepting information from pesti-
cide industry studies conducted on humans.
The decision preempted the report from the
U.S. EPA SAB/SAP, which had for months
been deadlocked in their deliberations (Warrick
2000).
In November 2001, the Bush adminis-
tration reversed the decision of the Clinton
administration, indicating that it would now
accept data from human tests. The new policy,
which has not been formally announced or
acknowledged, appears to disregard the recom-
mendations of the U.S. EPA SAB/SAP Joint
Subcommittee on Data from Human Subjects
(Shogren 2001).
During 2001, the U.S. EPA evaluated
three trials in which human volunteers had
been subjected to doses of pesticides hundreds
of times greater than levels the U.S. EPA had
deemed safe. In one study conducted in
Lincoln, Nebraska, by a subcontractor to the
Dow Chemical Company, volunteers were
paid up to $460 to ingest doses of chlorpyri-
fos in concentrations up to 300 times higher
than the level the U.S. EPA considers safe
(Vedantam 2000). One female volunteer who
received the highest dose reported numbness
in her upper arms, which company officials
ruled “possibly” related to the pesticide.
Cholinesterase levels in her blood fell by
28%, a level unlikely due to chance. Other
female participants reported headaches, nau-
sea, vomiting, and intestinal cramps. Dow sci-
entists concluded that the pesticide did not
produce any symptoms because similar symp-
toms were also seen in volunteers given a
placebo and there was no clear dose–response
pattern (Vedantam 2000).
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announced another moratorium on human
tests after considering the results of testing that
exposed humans to pesticides. On 5 September
2002, the U.S. EPA signed a contract with the
National Academy of Sciences to create an
expert committee to examine ethical issues
related to human testing of pesticides (Reuters
Limited 2003).
Recently, CropLife America, a pesticide
manufacturers’ trade group, ﬁled suit against
the U.S. EPA. The lawsuit sought to compel
the agency to accept data from pesticide testing
on humans. In June 2003, the U.S. Court of
Appeals of the District of Columbia overturned
the 2001 ban prohibiting testing pesticides on
humans, opening the door for renewed debate
on the practice. The court reinstated the U.S.
EPA’s previous practice of considering third-
party human studies until the agency issues a
ﬁnal rule after gathering public comment and
the National Academy of Sciences (NAS) issues
its final report (Reuters Limited 2003). In
February 2004, the NAS concluded that the
U.S. EPA should be allowed to accept test data
from chemical companies that pay people to eat
pesticides as long as certain standards are met
(Vedantam 2004).
Ethical Issues
Improvements in the protection of human
research subjects have often followed tragedies
such as the Nazi experiments during World
War II, the making public of the Tuskegee
syphilis experiment in the 1970s, and the 1999
death of a research participant in a University
of Pennsylvania trial (Steinbrook 2002). The
Doctors Trial at the end of World War II led
to the establishment of the Nuremberg Code,
the ﬁrst clear source of guidance for the ethical
conduct of clinical research ([Anonymous]
1996; Beauchamp and Childress 1996;
Vanderpool 1996). Other guidelines include
the Declaration of Helsinki (World Medical
Association 1997), the Belmont Report
(National Commission for the Protection of
Human Subjects of Biomedical Research
1979), and International Ethical Guidelines for
Biomedical Research Involving Human
Subjects (CIOMS 1993).
The Common Rule. To protect human
subjects in federally funded research, 16 federal
agencies, including the U.S. EPA, signed on
to the Common Rule in 1991 (EWG 1999).
The Belmont Report (named for the meeting
site) provided the framework from which
the Common Rule was adopted (National
Commission for the Protection of Human
Subjects of Biomedical and Behavioral
Research 1979). The Common Rule applies to
research conducted by federal institutions as well
as nonfederal institutions that receive federal
funding. According to the Common Rule, all
investigators who conduct studies that receive
funding from any of the 16 federal agencies
bound by the Common Rule must obtain
informed consent from subjects (Steinbrook
2002). Additionally, the risks of participation
must be reasonable “in relation to anticipated
beneﬁts, if any, to subjects, and the importance
of the knowledge that may reasonably be
expected to result” (Steinbrook 2002). Any
institution covered by the Common Rule must
establish an institutional review board for over-
sight of human subjects research (Office of
Science and Technology Policy 1991). Some
federal agencies require protection of research
subjects that goes beyond the Common Rule:
For example, FDA regulations 21 CFR Part 50
and 21 CFR Part 56 provide additional protec-
tion to human subjects by specifying require-
ments for informed consent and institutional
review boards for clinical investigations regu-
lated by the FDA (1998a, 1998b). Institutions
that do not accept federal funding are not
bound by the Common Rule and therefore are
not required to establish institutional review
boards to oversee their research. Perhaps one-
fourth of all clinical research conducted in the
United States receives no federal oversight
(Lemonic and Goldstein 2002).
Biomonitoring. Biomonitoring, the meas-
urement of industrial chemicals in human tis-
sues and ﬂuids, has shown that all Americans
carry a quantity of industrial chemicals or
their metabolites in their blood, fat, mother’s
milk, semen, urine, and breath. This measure-
ment is termed the “body burden” (Thornton
et al. 2002). In March 2001, the Centers for
Disease Control and Prevention (CDC) pre-
sented its First National Report on Human
Exposure to Environmental Chemicals, the ﬁrst
of a planned series of annual studies of the
types and amounts of industrial chemicals
that American adults have in their blood and
urine (CDC 2001). One component of the
report was the measurement of the levels of
six urine metabolites from 28 organophos-
phate pesticides in a sample of U.S. citizens
>6years of age. The study demonstrated that
virtually all of the urine samples contained
measurable amounts of all six organophos-
phate metabolites tested (CDC 2001). Food
is an important source of this exposure, and a
recent study examining the presence of pesti-
cides in food demonstrated that among some
samples tested, almost 100% contained
residues of as many as 14 different pesticides
(Baker et al. 2002).
Biomonitoring studies have measured pes-
ticide levels in the breast milk of nursing
mothers in the United States (Savage 1981)
and have measured body burdens of organo-
phosphate pesticides in American children
(Eskenazi et al. 1999). The existence of pesti-
cide residues and their metabolites in human
breast milk and in children is of particular
concern because children are more heavily
exposed per kilogram of body weight and are
more vulnerable than adults to the effects of
pesticides (National Research Council 1993).
Infants and children have special characteris-
tics (growth, development, and metabolism)
that distinguish them from adults in their sus-
ceptibility to the toxic effects of pesticides.
Children also possess behavioral traits that
cause them to be exposed to higher doses of
pesticides (National Research Council 1993).
Public health scientists and practitioners
use biomonitoring information for tracking,
control, and treatment. Biomonitoring data
can also play a critical role in identifying novel
hazards and high-risk populations, tracking
trends in human exposure, and characterizing
exposure levels that pose health hazards.
Many workshop participants suggested
that biomonitoring provides important and
useful information for risk assessment, particu-
larly for determining patterns of exposure and
the risks that pesticides pose to children’s
health. Workshop participants agreed that
human biomonitoring should be conducted
for every pesticide that is currently in use or
present in the environment and posing human
exposure risks. They also recommended that
special consideration be given to assessing the
body burdens of pesticides in children.
Workshop Recommendations
The Need to Establish Ethical
Guidelines for U.S. EPA Studies
The U.S. EPA has no formal, detailed guide-
lines or requirements at the present time for
the ethical conduct of research submitted by
private corporations for use in making regula-
tory decisions. This contrasts with the fact that
the U.S. EPA applies the Common Rule
(Office of Science and Technology Policy
1991) for its own research. This gap has the
potential to give corporations that sponsor
pesticide testing on humans freedom to pro-
duce data without adherence to established
ethical standards for research. This lack of reg-
ulation and oversight is of great concern, par-
ticularly with regard to pesticide testing on
humans. Hence, there is a pressing need to
reverse the lack of oversight for pesticide
research in humans and to create a level play-
ing ﬁeld by requiring that all studies submit-
ted to the U.S. EPA for use in standard setting
must be consistent with the Common Rule.
The participants agreed unanimously to
the following recommendations:
Recommendation 1. The U.S. EPA must
establish ethical guidelines for all research it
conducts, sponsors, or accepts in registration
applications.
Recommendation 2. In its regulatory pro-
ceedings, the U.S. EPA must accept only
research that is consistent with Common
Rule requirements. No study that violates
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in applications to the U.S. EPA.
Recommendation 3. All research partici-
pants involved in studies that will be used in
developing U.S. EPA exposure guidelines
must be given adequate information for pro-
viding informed consent. To assure that par-
ticipants are not subjected to undisclosed risks
or harms, informed consent processes must be
consistent with Common Rule requirements.
Recommendation 4. U.S. EPA applicants
and grantees must be held accountable for the
ethical conduct of their research. Oversight
and enforcement mechanisms must be devel-
oped and implemented by the U.S. EPA to
ensure compliance with ethical guidelines.
Ethical Constraints on Research
The U.S. EPA has a fundamental responsibility
to protect the environment and thereby to safe-
guard human health (U.S. EPA 2002). In ful-
ﬁlling its responsibility to commission sound
research, U.S. EPA regulations must be
designed to minimize the risk, magnitude, and
duration of harm to humans. Accordingly, any
study involving the administration of a pesti-
cide to a human subject must be designed to
minimize harm while subjecting the participant
to no unreasonable risk.
Because of the possibility of adverse effects
related to human participation in studies
involving the administration of a pesticide, it
is imperative that all such studies be supervised
by a qualiﬁed physician. This physician must
take direct responsibility for the well-being of
the subjects.
Recommendation 5. Any study involving
the administration of pesticides to humans
must be supervised by a qualified physician.
This physician must have direct responsibility
for the well-being of those participating in the
study. The physician must have the authority
to intervene at any time to stop a study to
minimize harm and risk of harm to subjects.
A core tenet of medical ethics is that a
study should not knowingly do harm to
humans, unless the possibility exists that
the study will convey direct benefit to the
subjects. Research involving deliberate human
exposure to pesticide chemicals appears to
compromise this principle (Caplan and
Sankar 2002; Robertson and Gorovitz 2000;
Steinberg 2000). By definition, all pesticide
research designed to determine NOELs car-
ries risk of unknown consequence. These
potential risks include low-level health effects,
some of which may be delayed in onset and
follow the conclusion of the testing period.
Historically, such effects have been recorded
some time after some pesticide exposures that
were thought to be safe, notably after low-
dose exposure to some organophosphates,
including certain pesticides (Wesseling et al.
2002).
NOEL studies inherently violate various
ethical guidelines. Subjects are exposed to lev-
els of pesticides that carry significant health
risks. Also, there is no system in place to verify
that NOEL studies conducted by chemical
corporations are performed with the informed
consent of the participants. Because the U.S.
EPA does not require nongovernmental insti-
tutions to abide by any ethical protocol, the
procedures of the chemical companies are not
transparent. Additionally, the testing of pesti-
cides in adults bears little relevance to pediatric
toxicity.
Recommendation 6. No results obtained
from any NOEL studies in humans can be
considered in the formulation of exposure
guidelines by the U.S. EPA.
The possibility exists that manufacturers
could test pesticides in children as a way
to acquire data on developmental toxicity
required by FQPA. Grave concern—scientiﬁc
as well as ethical—surrounds this possibility.
Biologically, children are more vulnerable than
adults to the effects of many pesticides. They
are particularly at risk of impacts on develop-
ment, which may result in lifelong damage to
health and function (National Research
Council 1993). Ethically, it is not conceivable
that a child can give informed consent to a
study of pesticide administration to humans.
Recommendation 7. Under no circum-
stances can children serve as subjects in stud-
ies in which they are deliberately exposed to
pesticides.
The quality of scientific research is an
essential component of the ethical conduct of
science. Research protocols that are funda-
mentally ﬂawed are unjustiﬁable.
Recommendation 8. Any study that is not
scientifically valid—for example, does not
include a sufﬁcient number of subjects to pro-
vide statistically valid answers to the questions
under investigation—must not be considered
in standard setting.
To minimize harm to humans and to
avoid subjecting humans to unreasonable
risks, it is necessary to begin studies by testing
pesticides in animals. There are special consid-
erations involved in the testing of pesticides in
animals.
Recommendation 9. Research on animals
must precede research on humans.
Recommendation 10. Animals must not
be used in studies unless accurate and useful
information can be obtained.
Biomonitoring provides important and
useful information for risk assessment, partic-
ularly for determining patterns of exposure.
Given the current lack of knowledge about
body burdens of pesticides in humans and
particularly in children, it is imperative that
biomonitoring be carried out to determine
the body burdens of pesticides in the general
population (Oleskey and McCally 2001).
Recommendation 11. Human biomonitor-
ing must be conducted for every pesticide that
is currently in use or present in the environ-
ment and that poses human exposure risks.
Special consideration must be paid to the
body burdens of pesticides in children.
Research on human subjects performed in
countries outside the United States for U.S.
corporations or agencies is especially controver-
sial (Angell 1997; Varmus and Satcher 1997).
Guidelines must be enacted to prohibit the
export to other nations of research deemed
unacceptable in the United States. Of particular
concern is the potential exploitation of subjects
in studies carried out in developing nations.
Recommendation 12. It is not acceptable to
conduct a study involving humans in a devel-
oping nation when the risks and harms
involved in the study would be considered
unacceptable in an industrially developed
nation. It is not acceptable to submit data from
such studies in regulatory decision making in
the United States. The U.S. EPA must not
accept studies performed in foreign countries
and conducted according to protocols that
would not be accepted in the United States.
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